The new results show stabilization of disease already from week 6 and confirm the unprecedented increase in lung function over timeVicore will accelerate clinical developmentInvitation to conference
Vicore announces new data from the IPF AIR trial further strengthening the benefit-risk profile of C21 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Vicore Pharma Holding AB (publ) ( Vicore ) pioneering development of angiotensin II type 2 receptor agonists (ATRAGs), today announces positive.